These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28756716)

  • 1. Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view.
    Golfieri L; Gitto S; Morelli MC; Pinna AD; Grandi S; Andreone P
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):759-765. PubMed ID: 28756716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
    Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hepatitis C before and after liver transplantation].
    Llovet LP; Rodríguez-Tajes S; Londoño MC
    Gastroenterol Hepatol; 2016 May; 39(5):344-51. PubMed ID: 26547614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
    Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
    World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine.
    Hüsing A; Kabar I; Schmidt HH; Heinzow HS
    Int J Mol Sci; 2015 Aug; 16(8):18033-53. PubMed ID: 26251895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis.
    Paterson DL; Gayowski T; Wannstedt CF; Wagener MM; Marino IR; Vargas H; Laskus T; Rakela J; Singh N
    Clin Transplant; 2000 Feb; 14(1):48-54. PubMed ID: 10693635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.
    Coilly A; Samuel D
    J Hepatol; 2016 Jan; 64(1):226-31. PubMed ID: 26375245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C: New challenges in liver transplantation.
    Filipec Kanizaj T; Kunac N
    World J Gastroenterol; 2015 May; 21(19):5768-77. PubMed ID: 26019441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
    Chhatwal J; Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DM; Chung RT
    Hepatology; 2017 Mar; 65(3):777-788. PubMed ID: 27906468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
    García-Reyne A; Lumbreras C; Fernández I; Colina F; Abradelo M; Magan P; San-Juan R; Manrique A; López-Medrano F; Fuertes A; Lizasoain M; Moreno E; Aguado JM
    Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent viral liver disease (hepatitis B and C) after liver transplantation.
    Olivera-Martínez MA; Gallegos-Orozco JF
    Arch Med Res; 2007 Aug; 38(6):691-701. PubMed ID: 17613360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?
    Donato MF; Monico S; Malinverno F; Aghemo A; Maggioni M; Reggiani P; Colombo M
    Liver Int; 2015 Jan; 35(1):1-4. PubMed ID: 25074044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C.
    Kornberg A; Küpper B; Tannapfel A; Thrum K; Bärthel E; Habrecht O; Settmacher U
    Transplantation; 2008 Aug; 86(3):469-73. PubMed ID: 18698252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Ueda Y; Uemoto S
    Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus and liver transplantation: where do we stand?
    Burra P; De Martin E; Zanetto A; Senzolo M; Russo FP; Zanus G; Fagiuoli S
    Transpl Int; 2016 Feb; 29(2):135-52. PubMed ID: 26199060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
    Mandorfer M; Payer BA; Scheiner B; Breitenecker F; Aichelburg MC; Grabmeier-Pfistershammer K; Rieger A; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2014 Jan; 34(1):69-77. PubMed ID: 23890125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.
    Gitto S; Belli LS; Vukotic R; Lorenzini S; Airoldi A; Cicero AF; Vangeli M; Brodosi L; Panno AM; Di Donato R; Cescon M; Grazi GL; De Carlis L; Pinna AD; Bernardi M; Andreone P
    World J Gastroenterol; 2015 Apr; 21(13):3912-20. PubMed ID: 25852276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.